GoodRx Holdings (GDRX) Preferred Stock Liabilities (2019 - 2020)

GoodRx Holdings has disclosed Preferred Stock Liabilities across 2 years of filings, most recently posting $737.0 million for Q2 2020.

• In Q2 2020, Preferred Stock Liabilities changed N/A year-over-year to $737.0 million; the TTM figure through Jun 2020 stood at $737.0 million (changed N/A YoY), while the FY2019 annual figure was $737.0 million, changed 0.0% from the prior year.
• Preferred Stock Liabilities came in at $737.0 million for Q2 2020 at GoodRx Holdings, roughly flat from $737.0 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $737.0 million in Q3 2019 to a low of $737.0 million in Q3 2019.